Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
BATL
|
Franklin Resources Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 300,000 Reduced 0.65% |
$2,130,000
$7.1 p/Share
|
Nov 13
2017 |
MED
|
Welling Glenn W.
Director |
SELL
Open market or private sale
|
Indirect | 250,000 Reduced 35.95% |
$16,250,000
$65.0 p/Share
|
Nov 13
2017 |
CRSP
|
Celgene Corp /De/
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 65,093 Reduced 1.4% |
$1,156,052
$17.76 p/Share
|
Nov 13
2017 |
SQ
|
Ajmere Dale
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 2,840 Reduced 2.39% |
$113,600
$40.0 p/Share
|
Nov 13
2017 |
ATEX
|
Owl Creek Asset Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,046 Added 0.23% |
$146,334
$29.0 p/Share
|
Nov 13
2017 |
QUMU
|
Harbert Discovery Fund, LP
Director |
BUY
Open market or private purchase
|
Direct | 87,300 Added 6.78% |
$214,758
$2.46 p/Share
|
Nov 13
2017 |
JASN
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 2,415 Added 0.17% |
$4,975
$2.06 p/Share
|
Nov 13
2017 |
JASN
|
Wynnefield Partners Small Cap Value LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,127 Added 0.16% |
$10,562
$2.06 p/Share
|
Nov 13
2017 |
JOE
|
Fairholme Capital Management LLC
Director |
BUY
Open market or private purchase
|
Direct | 15,950 Added 17.54% |
$294,756
$18.48 p/Share
|
Nov 13
2017 |
JOE
|
Fairholme Capital Management LLC
Director |
BUY
Open market or private purchase
|
Indirect | 18,050 Added 0.07% |
$333,564
$18.48 p/Share
|
Nov 13
2017 |
LXRX
|
Invus Public Equities, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 215,133 Added 15.71% |
$2,097,547
$9.75 p/Share
|
Nov 13
2017 |
S
|
Softbank Group Corp
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,042,166 Added 0.03% |
$6,242,574
$5.99 p/Share
|
Nov 13
2017 |
PRTY
|
James M Harrison
Director |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 5.9% |
$225,400
$11.27 p/Share
|
Nov 13
2017 |
SMMF
|
Gary L Hinkle
Director |
BUY
Open market or private purchase
|
Direct | 1,708 Added 0.46% |
$42,871
$25.1 p/Share
|
Nov 13
2017 |
CHN
|
City Of London Investment Group PLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,600 Added 0.25% |
$120,848
$21.58 p/Share
|
Nov 13
2017 |
GROW
|
Frank E Holmes
CEO/CIO |
BUY
Open market or private purchase
|
Direct | 1,000 Added 0.41% |
$2,710
$2.71 p/Share
|
Nov 13
2017 |
APLS
|
Cormorant Asset Management, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1,071,428 Added 23.57% |
$14,999,992
$14.0 p/Share
|
Nov 13
2017 |
PCF
|
Bulldog Investors, LLP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 7,000 Added 0.57% |
$62,440
$8.92 p/Share
|
Nov 13
2017 |
WVE
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect | 400,000 Added 5.07% |
$9,320,000
$23.3 p/Share
|
Nov 13
2017 |
TRN
|
Value Act Holdings, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 125,000 Added 0.68% |
$4,111,250
$32.89 p/Share
|
Nov 13
2017 |
CORR
|
David J Schulte
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 50,822 Reduced 100.0% |
$1,234,975
$24.3 p/Share
|
Nov 12
2017 |
ATEX
|
Owl Creek Asset Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,100 Added 0.1% |
$61,740
$29.4 p/Share
|
Nov 10
2017 |
PCF
|
Bulldog Investors, LLP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 8,400 Added 0.68% |
$74,928
$8.92 p/Share
|
Nov 10
2017 |
QUMU
|
Harbert Discovery Fund, LP
Director |
BUY
Open market or private purchase
|
Direct | 6,850 Added 0.61% |
$16,783
$2.45 p/Share
|
Nov 10
2017 |
JOE
|
Fairholme Capital Management LLC
Director |
BUY
Open market or private purchase
|
Indirect | 1,600 Added 0.01% |
$28,960
$18.1 p/Share
|
Nov 10
2017 |
GAM-PB
|
Anang K. Majmudar
Senior Vice-President |
BUY
Open market or private purchase
|
Direct | 708 Added 29.61% |
$23,456
$33.13 p/Share
|
Nov 10
2017 |
CHN
|
City Of London Investment Group PLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,304 Added 0.86% |
$49,444
$21.46 p/Share
|
Nov 10
2017 |
CZNC
|
Leo F Lambert |
BUY
Open market or private purchase
|
Direct | 62 Added 0.28% |
$1,471
$23.73 p/Share
|
Nov 10
2017 |
CZNC
|
Leo F Lambert |
BUY
Open market or private purchase
|
Indirect | 18 Added 1.07% |
$427
$23.73 p/Share
|
Nov 10
2017 |
LXRX
|
Invus Public Equities, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 145,680 Added 13.43% |
$1,418,923
$9.74 p/Share
|
Nov 10
2017 |
GROW
|
Frank E Holmes
CEO/CIO |
BUY
Open market or private purchase
|
Direct | 1,000 Added 0.41% |
$2,980
$2.98 p/Share
|
Nov 10
2017 |
S
|
Softbank Group Corp
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,161,495 Added 0.06% |
$13,358,039
$6.18 p/Share
|
Nov 10
2017 |
NIC
|
John Nicholas Dykema
Director |
BUY
Open market or private purchase
|
Direct | 2,628 Added 3.43% |
$146,905
$55.9 p/Share
|
Nov 10
2017 |
TSLA
|
Eric Branderiz
VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 1,736 Reduced 100.0% |
$524,810
$302.31 p/Share
|
Nov 10
2017 |
PLXS
|
Todd P. Kelsey
President & CEO |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 11.97% |
$459,675
$61.29 p/Share
|
Nov 10
2017 |
GL
|
Vern D Herbel |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 45.92% |
$2,097,250
$83.89 p/Share
|
Nov 10
2017 |
CB
|
Sean Ringsted
EVP, Chief Risk Officer and* |
SELL
Open market or private sale
|
Direct | 28,730 Reduced 15.48% |
$4,350,297
$151.42 p/Share
|
Nov 10
2017 |
ALL
|
Suren Gupta |
SELL
Open market or private sale
|
Direct | 103,242 Reduced 80.94% |
$10,180,694
$98.61 p/Share
|
Nov 10
2017 |
SF
|
Richard J Himelfarb
Senior Vice President |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 22.36% |
$1,572,300
$52.41 p/Share
|
Nov 10
2017 |
SF
|
Victor Nesi
Co-President |
SELL
Open market or private sale
|
Direct | 24,888 Reduced 21.74% |
$1,305,127
$52.44 p/Share
|
Nov 10
2017 |
SF
|
Thomas B. Michaud
Senior Vice President |
SELL
Open market or private sale
|
Direct | 24,536 Reduced 28.82% |
$1,285,686
$52.4 p/Share
|
Nov 10
2017 |
SF
|
James M Oates
Director |
SELL
Open market or private sale
|
Direct | 1,768 Reduced 5.81% |
$92,413
$52.27 p/Share
|
Nov 10
2017 |
SGYP
|
Paulson & Co. Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 8,750,000 Reduced 36.36% |
$24,674,999
$2.82 p/Share
|
Nov 10
2017 |
GDP
|
Franklin Resources Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,700 Reduced 0.14% |
$63,042
$11.06 p/Share
|
Nov 10
2017 |
CRSP
|
Celgene Corp /De/
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.21% |
$172,800
$17.28 p/Share
|
Nov 10
2017 |
WST
|
Patrick J Zenner |
SELL
Open market or private sale
|
Direct | 335 Reduced 0.5% |
$34,016
$101.54 p/Share
|
Nov 10
2017 |
WTW
|
Jeffrey W Ubben
Director |
SELL
Open market or private sale
|
Indirect | 120,000 Reduced 5.08% |
$19,366,800
$161.39 p/Share
|
Nov 10
2017 |
LLY
|
Alfonso G Zulueta
SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct | 2,003 Reduced 4.39% |
$167,591
$83.67 p/Share
|
Nov 10
2017 |
ABBV
|
Michael Severino
Vice Chairman |
SELL
Open market or private sale
|
Direct | 25,633 Reduced 18.24% |
$2,427,189
$94.69 p/Share
|
Nov 10
2017 |
COST
|
Richard A Galanti
Executive Vice President |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 7.85% |
$512,850
$170.95 p/Share
|
Nov 10
2017 |